This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Vyera loses bid to dismiss FTC, states' federal antitrust claims, but gets Pennsylvania law claim thrown out

( August 18, 2020, 19:42 GMT | Official Statement) -- MLex Summary: Vyera Pharmaceuticals must face monopolization claims brought by the US Federal Trade Commission and several state attorneys general offices, US District Judge Denise Cote said in a ruling denying the company's motion to dismiss claims under the Sherman Act and FTC Act. However, Cote did dismiss claims under Pennsylvania's Unfair Trade Practices and Consumer Protection law because the plaintiffs failed to identify fraudulent behavior by Vyera and the law fails to expressly identify monopolistic behavior, according to the ruling.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections